Related Experiment Video
Updated: Jul 9, 2026
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Dynamic Versus Static Cardiac Biomarker Assessment for Prognostic Stratification After Percutaneous Coronary
Nabila N Anika1,2, Mohamed K Said3, Hamza Al Balushi4
1General Surgery, University of South Florida Health, Florida, USA.
Cureus
|July 8, 2026
Summary
Serial cardiac biomarker assessment, particularly NT-proBNP, may improve risk prediction in percutaneous coronary intervention (PCI) patients compared to single measurements. Dynamic evaluation offers insights into ischemic burden and reperfusion dynamics.
Area of Science:
- Cardiology
- Biomarker Research
- Interventional Cardiology
Background:
- Cardiac biomarkers are crucial for risk stratification in percutaneous coronary intervention (PCI).
- Optimal timing and mode of cardiac biomarker assessment post-PCI remain unclear.
- Current guidelines lack definitive recommendations on serial vs. single biomarker measurements.
Purpose of the Study:
- To systematically review and evaluate the prognostic significance of serial, delta, and peak cardiac biomarker measurements versus single baseline measurements in PCI patients.
- To compare the predictive value of different cardiac biomarkers (troponin, NT-proBNP, CK-MB) and assessment strategies.
- To identify optimal biomarker assessment strategies for improved risk stratification in PCI.
Main Methods:
- Systematic literature review of PubMed/MEDLINE, Scopus, and Web of Science.
- Inclusion of nine cohort studies across diverse PCI settings (elective, primary, CTO).
- Assessment of various biomarkers (high-sensitivity troponin, conventional troponin, NT-proBNP, CK-MB) using baseline, peak, serial, and delta strategies.
Main Results:
- Baseline troponin levels consistently predict outcomes post-PCI.
- Post-procedural troponin elevations show variable prognostic value, dependent on thresholds.
- Serial assessment of N-terminal pro-B-type natriuretic peptide (NT-proBNP) enhances prognostic discrimination and reflects pathophysiologic processes.
Conclusions:
- Dynamic biomarker assessment, especially NT-proBNP, may offer incremental prognostic value over static measurements in PCI.
- Clinical integration of dynamic biomarker assessment requires further validation.
- A nuanced, context-dependent approach to biomarker interpretation is supported for PCI populations.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...